2023
Entrant Company
Category
Client's Name
Country / Region
Unlocking the Proteome -The NULISA™ Platform sets a new standard in proteomic analysis with attomolar sensitivity, allowing for unprecedented biomarker detection and quantitation.
By leveraging a proprietary sequential immunocomplex capture and release mechanism and the latest advances in Next Generation Sequencing (NGS), the NULISA technology provides both ultra-high sensitivity and scalable multiplexing.
Credits
Entrant Company
Rou-Yun Ho
Category
Student Submission - Student Product Design
Country / Region
Taiwan
Entrant Company
ArtVersion
Category
Website - Branding
Country / Region
United States
Entrant Company
Music With No Expiration®
Category
Corporate Social Responsibility - Pro Bono (Free)
Country / Region
United States
Entrant Company
Göker Group & Level Advertising USA
Category
Website - Corporation
Country / Region
Turkey